In this short report, we demonstrated that treatment of PBMCs from ten hospitalized COVID-19 patients with C24D resulted in the reactivation of CD45 key-signaling molecules: Lck, ZAP-70 and VAV-1. The gene discussed is PTPRC; the disease is COVID-19.